GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Return-on-Tangible-Asset

MicroTech Medical (Hangzhou) Co (HKSE:02235) Return-on-Tangible-Asset : -9.73% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. MicroTech Medical (Hangzhou) Co's annualized Net Income for the quarter that ended in Dec. 2023 was HK$-232.7 Mil. MicroTech Medical (Hangzhou) Co's average total tangible assets for the quarter that ended in Dec. 2023 was HK$2,390.5 Mil. Therefore, MicroTech Medical (Hangzhou) Co's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was -9.73%.

The historical rank and industry rank for MicroTech Medical (Hangzhou) Co's Return-on-Tangible-Asset or its related term are showing as below:

HKSE:02235' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -31.62   Med: -5.62   Max: -1.46
Current: -5.6

During the past 5 years, MicroTech Medical (Hangzhou) Co's highest Return-on-Tangible-Asset was -1.46%. The lowest was -31.62%. And the median was -5.62%.

HKSE:02235's Return-on-Tangible-Asset is ranked worse than
54.19% of 860 companies
in the Medical Devices & Instruments industry
Industry Median: -2.745 vs HKSE:02235: -5.60

MicroTech Medical (Hangzhou) Co Return-on-Tangible-Asset Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroTech Medical (Hangzhou) Co Return-on-Tangible-Asset Chart

MicroTech Medical (Hangzhou) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
-31.62 -24.29 -3.15 -1.46 -5.62

MicroTech Medical (Hangzhou) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Return-on-Tangible-Asset Get a 7-Day Free Trial -2.51 -0.67 -2.31 -1.63 -9.73

Competitive Comparison of MicroTech Medical (Hangzhou) Co's Return-on-Tangible-Asset

For the Medical Devices subindustry, MicroTech Medical (Hangzhou) Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroTech Medical (Hangzhou) Co's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroTech Medical (Hangzhou) Co's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where MicroTech Medical (Hangzhou) Co's Return-on-Tangible-Asset falls into.



MicroTech Medical (Hangzhou) Co Return-on-Tangible-Asset Calculation

MicroTech Medical (Hangzhou) Co's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-136.74/( (2540.904+2324.324)/ 2 )
=-136.74/2432.614
=-5.62 %

MicroTech Medical (Hangzhou) Co's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=-232.654/( (2456.733+2324.324)/ 2 )
=-232.654/2390.5285
=-9.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data.


MicroTech Medical (Hangzhou) Co  (HKSE:02235) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


MicroTech Medical (Hangzhou) Co Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroTech Medical (Hangzhou) Co (HKSE:02235) Business Description

Traded in Other Exchanges
N/A
Address
No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN
MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.
Executives
Zheng Pan
Master Summer Limited 2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd 2201 Interest of corporation controlled by you
Cdbi Partners Fund Ii, L.p. 2201 Interest of corporation controlled by you
Cdbi Partners Fund I, L.p. 2201 Interest of corporation controlled by you
Cdbi Gp, Ltd 2201 Interest of corporation controlled by you
Cd Capital Healthcare Fund V, L.p. 2201 Interest of corporation controlled by you
Cd Capital Gp Ltd 2201 Interest of corporation controlled by you
Zhe Jiang Jiu Ren Zi Ben Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd. 2201 Interest of corporation controlled by you
Qiming Gp V, L.p. 2201 Interest of corporation controlled by you
Qiming Venture Partners V, L.p. 2201 Interest of corporation controlled by you
Qm32 Limited 2101 Beneficial owner
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Lav Evergreen (hong Kong) Co., Limited 2101 Beneficial owner

MicroTech Medical (Hangzhou) Co (HKSE:02235) Headlines

No Headlines